2024年5月5日发(作者：黎雅容)
参考文献目录
第一章 疾病概论
[1] 肖献忠. 病理生理学[M]. 2版. 北京：高等教育出版社，2008.
[2] 金惠铭，王建枝. 病理生理学[M]. 7版. 北京：人民卫生出版社，2008
[3] Alberts B, Johnson A, Lewis J, et al. Molecular biology of the cell [M], 5
th
ed, New York,
Garland Science, 2008.
[4] Huether SE, McCance KL. Understanding Pathophysiology [M], 4 ed, St. Louis, MO,
Mosby Elsevier, 2008.
[5] Copstead LC, Banasik JL. Pathophysiology [M], 4
th
ed, St. Louis, Missouri, Saunders Elsevier,
2010
[6] Gerber A, Hentzelt F, Lauterbach KW. Can evidence-based medicine implicitly rely on
current concepts of disease or does it have to develop its own definition [J]? J Med Ethics
2007; 33(7): 394-9.
[7] Ideker T, Sharan R. Protein networks in disease [J]. Genome Res 2008; 18(4): 644-52.
[8] Holtz TH, Holmes SM, Stonington S, et al. Health is still social: contemporary examples in
the age of the genome [J]. PLoS Med 2006; 3(10): e419.
[9] Baudot A, Gómez-López G, Valencia A. Translational disease interpretation with molecular
networks [J]. Genome Biol 2009; 10(6): 221.
[10] Crews D, McLachlan JA. Epigenetics, evolution, endocrine disruption, health, and disease [J].
Endocrinology. 2006; 147(6 Suppl): S4-10.
th
第二章 疾病的系统生物学
[1] Kitano H. Systems biology. Science 2002; 295(5560): 1662-1664.
[2] Hood L, Rowen L, Galas DJ, Aitchison JD. Systems biology at the Institute for Systems
Biology. Brief Funct Genomic Proteomic 2008; 7(4): 239-248.
[3] Hood L. Systems biology: integrating technology, biology, and computation. Mech Ageing
Dev 2003; 124(1): 9-16.
[4] Ideker T, Galitski T, Hood L. A new approach to decoding life: systems biology. Annu Rev
Genomics Hum Genet 2001; 2: 343-372.
1
[5] 蒋太交，薛艳红，徐涛. 系统生物学—生命科学的新领域. 生物化学与生物物理进展
2004; 31(11): 957-964.
[6] Wang L, Weinshilboum RM. Pharmacogenomics: candidate gene identification, functional
validation and mechanisms. Hum Mol Genet 2008; 17(R2): R174-179.
[7] Wilson ID. Drugs, bugs, and personalized medicine: pharmacometabonomics enters the ring.
Proc Natl Acad Sci USA 2009; 106(34): 14187-14188.
[8] CB Clish, E Davidov, M Oresic, et ative biological analysis of the APOE*3-leiden
transgenic mouse[J].OMICS,2004,8(1):3-13.
[9] Miehailova A, MeCulloch study of ATP and ADP buffering, transport of Ca
2+
and
Mg
2+
, and regulation of ion pumps in ventricular myocyte. Biophys J 2001;81:614-629．
[10] Wee KB, Aguda BD. Akt versus P53 in a network of oncogenes and tumor suppressor genes
regulating cell survival and death．Biophys J, 2006, 91(3): 857-865.
第三章 细胞信号转导与疾病
[1] 卢建, 余应年, 徐仁宝主编. 受体信号转导系统与疾病 [M]. 济南: 山东科技出版社.
1999,1~18, 164~189, 558~596, 624~641.
[2] 卢建. 细胞信号转导异常与疾病 [M]. 见金惠铭, 王建枝主编．病理生理学. 北京: 人民
卫生出版社. 2007.
[3] Toren Finkel and J. Silvio Gutkind
(Editors-in-Chief):
Signal transduction and human
disease [M]. John Wiley & Sons. Inc, 2003.
[4] Friedrich Marks, Ursula Klingmüller, and Karin Müller-Decker
(Editors-in-Chief):
Cellular Signal Processing: An Introduction to the Molecular Mechanisms of Signal
Transduction [M]. Garland Science, 2008.
[5] McCubrey JA, Steelman LS, Abrams SL, et al. Roles of the RAF/MEK/ERK and
PI3K/PTEN/AKT pathways in malignant transformation and drug resistance [J]. Adv Enzyme
Regul. 2006; 46:249-79.
[6] Gutkind JS. Regulation of mitogen-activated protein kinase signaling networks by G
protein-coupled receptors. Sci STKE. 2000 Jul 11; 2000(40):RE1.
[7] Ludwig MG,Vanek M,Guerini D,Gasser JA,Jones CE,Junker U,Hofstetter H,Wolf
2
2024年5月5日发(作者：黎雅容)
参考文献目录
第一章 疾病概论
[1] 肖献忠. 病理生理学[M]. 2版. 北京：高等教育出版社，2008.
[2] 金惠铭，王建枝. 病理生理学[M]. 7版. 北京：人民卫生出版社，2008
[3] Alberts B, Johnson A, Lewis J, et al. Molecular biology of the cell [M], 5
th
ed, New York,
Garland Science, 2008.
[4] Huether SE, McCance KL. Understanding Pathophysiology [M], 4 ed, St. Louis, MO,
Mosby Elsevier, 2008.
[5] Copstead LC, Banasik JL. Pathophysiology [M], 4
th
ed, St. Louis, Missouri, Saunders Elsevier,
2010
[6] Gerber A, Hentzelt F, Lauterbach KW. Can evidence-based medicine implicitly rely on
current concepts of disease or does it have to develop its own definition [J]? J Med Ethics
2007; 33(7): 394-9.
[7] Ideker T, Sharan R. Protein networks in disease [J]. Genome Res 2008; 18(4): 644-52.
[8] Holtz TH, Holmes SM, Stonington S, et al. Health is still social: contemporary examples in
the age of the genome [J]. PLoS Med 2006; 3(10): e419.
[9] Baudot A, Gómez-López G, Valencia A. Translational disease interpretation with molecular
networks [J]. Genome Biol 2009; 10(6): 221.
[10] Crews D, McLachlan JA. Epigenetics, evolution, endocrine disruption, health, and disease [J].
Endocrinology. 2006; 147(6 Suppl): S4-10.
th
第二章 疾病的系统生物学
[1] Kitano H. Systems biology. Science 2002; 295(5560): 1662-1664.
[2] Hood L, Rowen L, Galas DJ, Aitchison JD. Systems biology at the Institute for Systems
Biology. Brief Funct Genomic Proteomic 2008; 7(4): 239-248.
[3] Hood L. Systems biology: integrating technology, biology, and computation. Mech Ageing
Dev 2003; 124(1): 9-16.
[4] Ideker T, Galitski T, Hood L. A new approach to decoding life: systems biology. Annu Rev
Genomics Hum Genet 2001; 2: 343-372.
1
[5] 蒋太交，薛艳红，徐涛. 系统生物学—生命科学的新领域. 生物化学与生物物理进展
2004; 31(11): 957-964.
[6] Wang L, Weinshilboum RM. Pharmacogenomics: candidate gene identification, functional
validation and mechanisms. Hum Mol Genet 2008; 17(R2): R174-179.
[7] Wilson ID. Drugs, bugs, and personalized medicine: pharmacometabonomics enters the ring.
Proc Natl Acad Sci USA 2009; 106(34): 14187-14188.
[8] CB Clish, E Davidov, M Oresic, et ative biological analysis of the APOE*3-leiden
transgenic mouse[J].OMICS,2004,8(1):3-13.
[9] Miehailova A, MeCulloch study of ATP and ADP buffering, transport of Ca
2+
and
Mg
2+
, and regulation of ion pumps in ventricular myocyte. Biophys J 2001;81:614-629．
[10] Wee KB, Aguda BD. Akt versus P53 in a network of oncogenes and tumor suppressor genes
regulating cell survival and death．Biophys J, 2006, 91(3): 857-865.
第三章 细胞信号转导与疾病
[1] 卢建, 余应年, 徐仁宝主编. 受体信号转导系统与疾病 [M]. 济南: 山东科技出版社.
1999,1~18, 164~189, 558~596, 624~641.
[2] 卢建. 细胞信号转导异常与疾病 [M]. 见金惠铭, 王建枝主编．病理生理学. 北京: 人民
卫生出版社. 2007.
[3] Toren Finkel and J. Silvio Gutkind
(Editors-in-Chief):
Signal transduction and human
disease [M]. John Wiley & Sons. Inc, 2003.
[4] Friedrich Marks, Ursula Klingmüller, and Karin Müller-Decker
(Editors-in-Chief):
Cellular Signal Processing: An Introduction to the Molecular Mechanisms of Signal
Transduction [M]. Garland Science, 2008.
[5] McCubrey JA, Steelman LS, Abrams SL, et al. Roles of the RAF/MEK/ERK and
PI3K/PTEN/AKT pathways in malignant transformation and drug resistance [J]. Adv Enzyme
Regul. 2006; 46:249-79.
[6] Gutkind JS. Regulation of mitogen-activated protein kinase signaling networks by G
protein-coupled receptors. Sci STKE. 2000 Jul 11; 2000(40):RE1.
[7] Ludwig MG,Vanek M,Guerini D,Gasser JA,Jones CE,Junker U,Hofstetter H,Wolf
2